Women's exposure to phthalates in relation to use of personal care products
Published in Journal of Exposure Science and Environmental Epidemiology, March 1, 2013 | Online publication on November 21, 2012
Author(s): Lauren E Parlett, Shanna H Swan, Antonia M Calafat
DOI: 10.1038/jes.2012.105 | Pubmed ID: 23168567
Abstract
Several phthalates, particularly diethyl phthalate (DEP) and di-n-butyl phthalate, can be used in personal care products (PCPs) to fix fragrance and hold color. We investigated associations between women's reported use of PCPs within the 24 h before urine collection and concentrations of several urinary phthalate metabolites. Between 2002 and 2005, 337 women provided spot urine samples and answered questions regarding their use of 13 PCPs at a follow-up visit 3-36 months after pregnancy. We examined associations between urinary concentrations of several phthalate metabolites and use of PCPs using linear regression. Use of individual PCPs ranged from 7% (nail polish) to 91% (deodorant). After adjusting for age, education, and urinary creatinine, women reporting use of perfume had 2.92 times higher (95% CI: 2.20-3.89) concentration of monoethyl phthalate (MEP; the primary metabolite of DEP) than other women. Other PCPs that were significantly associated with MEP concentrations included: hair spray, nail polish, and deodorant. MEP concentrations increased with the number of PCPs used. PCP use was widespread in this group of recently pregnant women. Women's use of PCPs, particularly of perfumes and fragranced products, was positively associated with urinary concentration of multiple phthalate metabolites.
Funding Transparency
This work was possible through:
- Grant/Award
Additional details:
- Swan - NIH - 1RC2ES018736 : Prenatal Bisphenol A and Sexually Dimorphic Neurodevelopment
- Swan - NIH - R01ES009916 : US Study of Semen Quality in Partners of Pregnant Women
- Paller - NIH - 5M01RR000400 : GCRC-General Clinical Research Center
- Wang - NIH - 5M01RR000425 : General Clinical Research Center
Tags
Analytic: factor analysis | multivariable regression
Data Source: patient survey | biospecimen
Research Focus: hormone disruptor exposures
Study Design: cross-sectional
Entry last updated (DMY): 24-11-2024.